FDA Orphan Drug Designation

Published: 25 November 2014 Khondrion has received an Orphan Drug Designation from the FDA of its frontrunner compound KH176, in the treatment of inherited mitochondrial respiratory chain diseases.

The release as fetched from its publisher. khondrion.com ↗